ACEMATE Tennis Robot S10 Gets 0 Prime Day Discount, with Bonus Gifts
Press Release

ACEMATE Tennis Robot S10 Gets $600 Prime Day Discount, with Bonus Gifts

HONG KONG, June 22, 2026 /PRNewswire/ — ACEMATE today announced a Prime Day promotion for the Acemate S10, its flagship AI tennis robot built for real-rally practice. From June 23 through June 30, the S10 will be available for $1,899, down $600 from its $2,499 MSRP, offering players a timely opportunity to upgrade their summer training […]

Read More
MDJM LTD Confirms Its Securities Are Quoted on the OTCQB Venture Market
Press Release

MDJM LTD Confirms Its Securities Are Quoted on the OTCQB Venture Market

LETHAM, Scotland, June 22, 2026 /PRNewswire/ — MDJM Ltd. (OTCQB: UOKAF) (the "Company"), an integrated global culture-driven asset management company, today confirmed that its Class A ordinary shares, par value US$0.875 per share, are currently quoted on the OTCQB Venture Market under the ticker symbol "UOKAF." The Company is issuing this announcement to clarify its […]

Read More
AMTD Group and AMTD IDEA Reaffirm Long-Term Commitment to TGE with a Two-Year Voluntary Lock-Up
Press Release

AMTD Group and AMTD IDEA Reaffirm Long-Term Commitment to TGE with a Two-Year Voluntary Lock-Up

PARIS, LONDON and NEW YORK, June 22, 2026 /PRNewswire/ — AMTD Group Inc. ("AMTD Group") and AMTD IDEA Group ("AMTD IDEA") (NYSE: AMTD; SGX: HKB) jointly announce that as co-founding shareholders of The Generation Essentials Group ("TGE") (NYSE: TGE; LSE: TGE), they fully echo and support the recent announcement of AMTD Digital Inc. ("AMTD Digital") […]

Read More
Block Reign Announces Completion of CertiK Review of Gnodi Blockchain
Press Release

Block Reign Announces Completion of CertiK Review of Gnodi Blockchain

Completed independent review reflects a proactive commitment to transparency, technical diligence and long-term confidence in the Gnodi ecosystem. OREM, Utah, June 22, 2026 /PRNewswire/ — Block Reign, Inc. today announced the completion of its independent CertiK review of the Gnodi Blockchain. The completed engagement reflects Block Reign’s proactive commitment to technical diligence, community visibility and responsible ecosystem […]

Read More
HOMRELEXA Brings Comfort-Driven, Multi-Use Office Chair to Prime Day 2026
Press Release

HOMRELEXA Brings Comfort-Driven, Multi-Use Office Chair to Prime Day 2026

NEW YORK, June 22, 2026 /PRNewswire/ — As Prime Day 2026 approaches, HOMRELEXA is spotlighting a multi-functional office chair designed to meet growing demand for versatile, comfort-driven home furniture. Available during the June 23-26 shopping event, the chair stands out for its rose-pink velvet finish and adaptable design. As part of the brand’s broader furniture and […]

Read More
The Container Arrived. The Real Test Had Just Begun. ChinaMarket's Global Journey
Press Release

The Container Arrived. The Real Test Had Just Begun. ChinaMarket's Global Journey

LINYI, China, June 22, 2026 /PRNewswire/ — In cross-border modular building projects, the biggest risk is rarely visible at the time of contract signing. It only becomes real when the containers arrive on site. Across Indonesia’s mining, infrastructure, construction, and industrial sectors, demand for prefabricated and modular building systems continues to grow rapidly. Project owners […]

Read More
NYSE Content Update: Cannes Lions International Festival of Creativity Begins
Press Release

NYSE Content Update: Cannes Lions International Festival of Creativity Begins

NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK, June 22, 2026 /PRNewswire/ — The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today’s NYSE Pre-market update for market insights before trading begins.  https://static.prnasia.com/pro/fec/jwplayer-7.12.1/jwplayer.js jwplayer.key=”3Fznr2BGJZtpwZmA+81lm048ks6+0NjLXyDdsO2YkfE=”   VanEck Gold Miners ETF celebrates 20 […]

Read More
Laboratoires Pierre Fabre receives European Commission Approval for BRAFTOVI® (encorafenib) in combination with cetuximab and FOLFOX (fluorouracil, leucovorin, and oxaliplatin) for the first-line treatment of adult patients with BRAFV600E-mutant metastatic colorectal cancer (mCRC)
Press Release

Laboratoires Pierre Fabre receives European Commission Approval for BRAFTOVI® (encorafenib) in combination with cetuximab and FOLFOX (fluorouracil, leucovorin, and oxaliplatin) for the first-line treatment of adult patients with BRAFV600E-mutant metastatic colorectal cancer (mCRC)

European approval is based on results from the Phase 3 BREAKWATER trial, which demonstrated that encorafenib in combination with cetuximab and mFOLFOX6 demonstrated a statistically significant improvement in the dual primary endpoints of objective response rate (ORR) and  progression-free survival (PFS), and a significant overall survival (OS) benefit, reducing the risk of death by 51% […]

Read More

Sign In

Register

Reset Password

Please enter your username or email address, you will receive a link to create a new password via email.